{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:59:02Z","timestamp":1761166742940,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.pupt.2020.101898","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T11:44:41Z","timestamp":1579607081000},"page":"101898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Dual use of bronchodilators versus monotherapy, and its impact on pulmonary rehabilitation in COPD patients"],"prefix":"10.1016","volume":"61","author":[{"given":"Vicente","family":"Benavides-Cordoba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Aviles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Ascuntar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Mosquera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2020.101898_bib1","first-page":"13","article-title":"COPD: the patient perspective","volume":"11 Spec","author":"Jones","year":"2016","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"5","key":"10.1016\/j.pupt.2020.101898_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00164-2019","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019","volume":"53","author":"Singh","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.pupt.2020.101898_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2174\/1574884712666170918150757","article-title":"Perioperative pulmonary medication management","volume":"12","author":"Renew","year":"2017","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.pupt.2020.101898_bib4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2147\/COPD.S130482","article-title":"LABA\/LAMA combinations versus LAMA monotherapy or LABA\/ICS in COPD: a systematic review and meta-analysis","volume":"12","author":"Rodrigo","year":"2017","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2020.101898_bib5","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2147\/COPD.S133307","article-title":"The effect of indacaterol\/glycopyrronium versus tiotropium or salmeterol\/fluticasone on the prevention of clinically important deterioration in COPD","volume":"12","author":"Anzueto","year":"2017","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2020.101898_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pupt.2017.04.002","article-title":"Role of dual bronchodilators in COPD: a review of the current evidence for indacaterol\/glycopyrronium","volume":"45","author":"Ficker","year":"2017","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"8","key":"10.1016\/j.pupt.2020.101898_bib7","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1164\/rccm.201309-1634ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation","volume":"188","author":"Spruit","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.pupt.2020.101898_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2020.101898_bib9","article-title":"Six-minute walk test: clinical role, technique, coding, and reimbursement","author":"Agarwala","year":"2019","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.pupt.2020.101898_bib10","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1164\/ajrccm.167.9.950","article-title":"ATS statement on six-minute walk test","volume":"167","author":"Brooks","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.pupt.2020.101898_bib11","first-page":"328","article-title":"ACSM's guidelines for exercise testing and prescription","volume":"58","author":"Ferguson","year":"2014","journal-title":"J. Can. Chiropr. Assoc."},{"issue":"4","key":"10.1016\/j.pupt.2020.101898_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1479972318761645","article-title":"Comparative analysis of the psychometric parameters of two quality-of-life questionnaires, the SGRQ and CAT, in the assessment of patients with COPD exacerbations during hospitalization: a multicenter study","volume":"15","author":"Folch Ayora","year":"2018","journal-title":"Chron. Respir. Dis."},{"issue":"7","key":"10.1016\/j.pupt.2020.101898_bib13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/resp.12864","article-title":"Exercise training in COPD: what is it about intensity?","volume":"21","author":"Morris","year":"2016","journal-title":"Respirology"},{"year":"2019","series-title":"Global Strategy for the Diagnosis, Management and Prevention of COPD - Global Initiative for Chronic Obstructive Lung Disease - GOLD","key":"10.1016\/j.pupt.2020.101898_bib14"},{"key":"10.1016\/j.pupt.2020.101898_bib15","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2147\/COPD.S91684","article-title":"Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial","volume":"10","author":"Santus","year":"2015","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"4","key":"10.1016\/j.pupt.2020.101898_bib16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3109\/15412555.2013.771162","article-title":"Combined therapy with tiotropium and formoterol in chronic obstructive pulmonary disease: effect on the 6-minute walk test","volume":"10","author":"Jayaram","year":"2013","journal-title":"COPD"},{"issue":"12","key":"10.1016\/j.pupt.2020.101898_bib17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jamda.2017.09.007","article-title":"Management of dyspnea and anxiety in chronic obstructive pulmonary disease: a critical review","volume":"18","author":"Yohannes","year":"2017","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"4","key":"10.1016\/j.pupt.2020.101898_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/HCR.0000000000000258","article-title":"Effect of baseline anxiety and depression symptoms on selected outcomes following pulmonary rehabilitation","volume":"37","author":"Cullen","year":"2017","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"issue":"4","key":"10.1016\/j.pupt.2020.101898_bib19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1586\/17476348.2015.1067608","article-title":"Assessment of pulmonary rehabilitation efficacy in chronic obstructive pulmonary disease patients using the chronic obstructive pulmonary disease assessment test","volume":"9","author":"Candemir","year":"2015","journal-title":"Expet Rev. Respir. Med."},{"issue":"5","key":"10.1016\/j.pupt.2020.101898_bib20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/HCR.0000000000000321","article-title":"Influence of disease severity and exercise limitation on exercise training intensity and load and health benefits from pulmonary rehabilitation in patients with COPD: an exploratory study","volume":"38","author":"Huynh","year":"2018","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"issue":"6","key":"10.1016\/j.pupt.2020.101898_bib21","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1183\/13993003.00350-2015","article-title":"Differential response to pulmonary rehabilitation in COPD: multidimensional profiling","volume":"46","author":"Spruit","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.pupt.2020.101898_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4187\/respcare.06336","article-title":"A high degree of dyspnea is associated with poor maximum exercise capacity in subjects with COPD with the same severity of air-flow obstruction","volume":"64","author":"Crisafulli","year":"2019","journal-title":"Respir. Care"},{"issue":"3","key":"10.1016\/j.pupt.2020.101898_bib23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.201310-1863PP","article-title":"Minimal clinically important differences in pharmacological trials","volume":"189","author":"Jones","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.pupt.2020.101898_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ijcp.12142","article-title":"When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed","volume":"67","author":"Citrome","year":"2013","journal-title":"Int. J. Clin. Pract."},{"issue":"6","key":"10.1016\/j.pupt.2020.101898_bib25","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1183\/09031936.00124013","article-title":"Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study","volume":"43","author":"Mahler","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2020.101898_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.rmed.2017.06.020","article-title":"Impact of LABA\/LAMA combination on exercise endurance and lung hyperinflation in COPD: a pair-wise and network meta-analysis","volume":"129","author":"Calzetta","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2020.101898_bib27","first-page":"1","article-title":"Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease","volume":"8","author":"Hataji","year":"2013","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"4","key":"10.1016\/j.pupt.2020.101898_bib28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2147\/COPD.S3935","article-title":"Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance","volume":"3","author":"Ambrosino","year":"2008","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"22","key":"10.1016\/j.pupt.2020.101898_bib29","article-title":"Efficacy of budesonide\/formoterol and tiotropium combination for the treatment of Chinese patients with chronic obstructive pulmonary disease","volume":"97","author":"Feng","year":"2018","journal-title":"Medicine (Baltim.)"},{"issue":"1","key":"10.1016\/j.pupt.2020.101898_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41533-017-0068-0","article-title":"Associations between self-rated health, sickness behaviour and inflammatory markers in primary care patients with allergic asthma: a longitudinal study","volume":"27","author":"Lodin","year":"2017","journal-title":"NPJ Prim. Care Respir. Med."},{"issue":"1","key":"10.1016\/j.pupt.2020.101898_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12931-017-0548-3","article-title":"Understanding the impact of symptoms on the burden of COPD","volume":"18","author":"Miravitlles","year":"2017","journal-title":"Respir. Res."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553919302755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553919302755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:28:44Z","timestamp":1761082124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553919302755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":31,"alternative-id":["S1094553919302755"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2020.101898","relation":{},"ISSN":["1094-5539"],"issn-type":[{"type":"print","value":"1094-5539"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual use of bronchodilators versus monotherapy, and its impact on pulmonary rehabilitation in COPD patients","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2020.101898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101898"}}